Shanghai INT Medical Instruments Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003NH7
HKD
34.12
0.48 (1.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
923.71
831.88
681.31
560.03
402.76
324.82
240.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
923.71
831.88
681.31
560.03
402.76
324.82
240.51
Raw Material Cost
340.76
347.82
294.67
227.70
139.35
127.02
105.63
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
283.12
246.37
214.10
161.41
95.93
85.63
61.91
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.63
3.53
0.95
0.76
0.10
2.07
1.81
Selling and Distribution Expenses
216.42
184.79
141.42
95.98
64.50
65.90
41.31
Other Expenses
-12.41
-11.08
-9.92
-5.38
-2.34
-5.28
-4.05
Total Expenditure (Excl Depreciation)
718.88
671.67
551.95
432.10
276.43
227.79
170.15
Operating Profit (PBDIT) excl Other Income
204.8
160.2
129.4
127.89999999999999
126.30000000000001
97
70.4
Other Income
38.96
34.53
39.59
25.16
25.12
31.95
9.84
Operating Profit (PBDIT)
330.39
247.30
212.07
189.52
176.13
150.11
91.87
Interest
2.63
3.53
0.95
0.76
0.10
2.07
1.81
Exceptional Items
-9.38
2.30
0.00
35.30
2.69
0.00
1.64
Gross Profit (PBDT)
582.95
484.07
386.64
332.33
263.41
197.80
134.88
Depreciation
86.59
52.55
43.12
36.42
24.68
21.14
12.96
Profit Before Tax
231.78
193.52
168.00
187.64
154.04
126.90
78.73
Tax
25.30
24.20
12.37
18.37
23.11
17.44
9.76
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
208.08
172.88
153.17
172.30
136.36
112.95
69.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
208.08
172.88
153.17
172.30
136.36
112.95
69.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.02
-3.57
2.47
-3.03
-5.44
-3.49
-0.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
206.06
169.32
155.63
169.27
130.93
109.46
68.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.06
1.1
1.12
1.22
1.19
1.12
0.0
Reserves
1,888.15
1,815.82
1,697.60
1,707.03
1,548.03
1,360.64
424.24
Earnings per share (EPS)
1.22
1.01
0.91
1.03
0.82
0.68
0.42
Diluted Earnings per share
1.22
1.01
0.91
1.03
0.82
0.68
0.42
Operating Profit Margin (Excl OI)
22.18%
19.26%
18.99%
22.84%
31.37%
29.87%
28.71%
Gross Profit Margin
34.47%
29.58%
30.99%
40.01%
44.37%
45.58%
38.13%
PAT Margin
22.53%
20.78%
22.48%
30.77%
33.86%
34.77%
28.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 11.03% vs 22.10% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 21.74% vs 8.80% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 36.94% vs 23.36% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -25.71% vs 250.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Shanghai INT Medical Instruments Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
923.71
3,364.02
-2,440.31
-72.54%
Other Operating Income
0.00
0.00
0.00
Total Operating income
923.71
3,364.02
-2,440.31
-72.54%
Raw Material Cost
340.76
1,565.15
-1,224.39
-78.23%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
283.12
1,532.25
-1,249.13
-81.52%
Power Cost
0
0
0.00
Manufacturing Expenses
2.63
51.65
-49.02
-94.91%
Selling and Distribution Expenses
216.42
1,174.77
-958.35
-81.58%
Other Expenses
-12.41
-154.03
141.62
91.94%
Total Expenditure (Excl Depreciation)
718.88
2,783.48
-2,064.60
-74.17%
Operating Profit (PBDIT) excl Other Income
204.83
580.54
-375.71
-64.72%
Other Income
38.96
2.01
36.95
1,838.31%
Operating Profit (PBDIT)
330.39
721.72
-391.33
-54.22%
Interest
2.63
51.65
-49.02
-94.91%
Exceptional Items
-9.38
-2.60
-6.78
-260.77%
Gross Profit (PBDT)
582.95
1,798.87
-1,215.92
-67.59%
Depreciation
86.59
139.17
-52.58
-37.78%
Profit Before Tax
231.78
528.30
-296.52
-56.13%
Tax
25.30
120.20
-94.90
-78.95%
Provisions and contingencies
0
0
0.00
Profit After Tax
208.08
408.00
-199.92
-49.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
208.08
408.00
-199.92
-49.00%
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.02
-1.06
-0.96
-90.57%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
206.06
406.94
-200.88
-49.36%
Equity Capital
0
0
0.00
Face Value
1.06
0.00
0.00
Reserves
1,888.15
2,715.87
-827.72
-30.48%
Earnings per share (EPS)
1.22
0.43
0.79
183.72%
Diluted Earnings per share
1.22
0.43
0.79
183.72%
Operating Profit Margin (Excl OI)
22.18%
17.26%
0.00
4.92%
Gross Profit Margin
34.47%
19.84%
0.00
14.63%
PAT Margin
22.53%
12.13%
0.00
10.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 92.37 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.03% vs 22.10% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 20.61 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.74% vs 8.80% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.14 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 36.94% vs 23.36% in Dec 2023

Annual - Interest
Interest 0.26 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -25.71% vs 250.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.18%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023